Somatic mutation and homozygous deletion of PTEN/MMAC1 gene at 10q23 in renal cell carcinoma

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 3841-3846

  Alimov, Andrei ^a,b,c   Li, Chunde ^a,c   Gizatullin, Rinat ^a,b   Fredriksson, Vanoohi ^a,c   Sundelin, Birgitta ^c   Klein, George ^b   Zabarovsky, Eugene ^a,b   Bergerheim, Ulf ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chromosome 10q23; Homozygous deletion; Loss of heterozygosity

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 10Q; CONTROLLED STUDY; EXON; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MARKER GENE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOMATIC MUTATION;

BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 10; DNA MUTATIONAL ANALYSIS; GENE DELETION; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0032779853     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Olson S: Tumors of the Kidney and Urinaty Tract. IRL Press: Munksgaard, Copenhagen/WB Saunders Co, Philadelphia, 1984.
2. Cancer Incidence in Sweden. The National Board of Health and Welfare, 1993.
3. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B: The Heidelberg classification of renalcell tumours. J Pathol 183(2): 131-133, 1997.
4. Van den Berg and Buys HCM: Involvement of multiple loci on chromosome 3 in renal cell cancer development. Cenes Chromosomes Cancer 19(2): 59-79, 1997.
5. Bentz M, Bergerheirn US, Li C, Joos S, Werner CA, Baudis M, Gnarra J, Merino MJ, Zbar B, Linehan WM, Lichter P: Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization. Cytogenet Cell Genet 75(1): 17-21, 1996.
6. Gnarra RJ, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh F-M, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM: Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genetics 7: 85-90, 1994.
7. Alkema MJ, Wiegant J, Raap AK, Berns A, van Lohuizen M: Characterization and chromosomal localization of the human protooncogene BMI-1. Hum Mol Cenet 2(10): 1597-603, 1993,
8. Ichimura K, Schmidt EE, Miyakawa A, Goike HM, Collins VP: Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 22: 9-15, 1998.
9. Tsuda T, Marinetti MR, Masuelli L, Cutler ML: The ras suppressor RSU-1 localized to 10q13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential. Oncogene 11(2): 397-403, 1995.
10. Bergerheim US, Kunimi K, Collins VP, Ekman P: Deletion mapping of chromosome 8, 10 and 16 in human prostatic carcinoma.. Genes Chromosomes Cancer 3(3): 215-220, 1991.
11. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner HS, Giovanella BC, Ittmann M, Tyko B, Hibshoosh H, Wigner MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, brest, and prostate cancer. Science 275: 1943-1947, 1997.
12. Bergerheim U, Nordenskjold M, Collins VP: Deletion mapping in human renal cell carcinoma, Cancer Res 49: 1390-1396, 1989.
13. Steck AP, Pershouse MP, Jasser SA, Yung A, Lin H, Ligon HA, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Ftye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancer. Nat Genet 15: 356-362, 1997.
14. Eagle LR, Brothman AR, Williams BJ, Atkin NB: Mutation of the MX1 gene in prostate cancer. Nature Genet 9: 249-255, 1995.
15. Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y, Saya H: Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Oncogene 16: 1009-1019, 1998.
16. Steck PA, Lin H, Langford LA, Jasser SA, Koul D, Yung WK, Pershouse MA: Functional and molecular analyses of 10q deletions in human gliomas.Genes Chromosomes Cancer 24 (2): 135-143, 1999.
17. Tomita Y, Bilim V, Kawasaki T, Takahahi K, Okan I, Magnusson K, Wiman KG: Frequent expression of Bcl-2 in renal cell carcinomas carrying wild-type p53. Int J Cancer 66: 322-325, 1996.
18. Bear A, Clayman RV, Elbers J, Limas C, Wang N, Stone K, Gebhard R, Prigge W, Palmer J: Characterization of two human cell lines (TK10, TK 164) of renal cell cancer. Cancer Res 47: 3856-3862, 1987.
19. Whang EY, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said WJ, Isaacs WB, Sawyers CI: Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci 95: 5246-5250, 1998.
20. Knudson AG: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437-1443, 1985.
21. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wielgenbus KK, von Deimling A, Poustka A: DMBT1, a new member of the SRSR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nature genetics 17: 32-39, 1997.
22. Cairns P, Evron E, Okami K, Halachmi N, Esteller M, Herman J G, Bose S, Wang SI, Parsons R, Sidrancky D: Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancer. Oncogene 16: 3215-3218, 1998.